XML 49 R35.htm IDEA: XBRL DOCUMENT

Parent Company Financial Statements (Tables)

12 Months Ended

Dec. 31, 2021

Parent Company Financial Statements (Unaudited)

Parent Statements of Operations and Comprehensive Loss

		2021				2020				2019

Equity in subsidiary losses		$	(34,400	)		$	(28,820	)		$	(21,745	)
Selling, general and administrative expenses			11,806				6,707				6,673

Operating loss			(46,206	)			(35,527	)			(28,418	)

Other (income) expense
Interest expense			1,031				677				1,392
Other (income) expense			(97	)			448				5,899

Loss before income taxes			(47,140	)			(36,652	)			(35,709	)

Income tax expense			7				7				7

Net loss			(47,147	)			(36,659	)			(35,716	)

Other comprehensive loss
Foreign currency translation adjustment			(27	)			(289	)			(249	)
Comprehensive loss		$	(47,174	)		$	(36,948	)		$	(35,965	)

Parent Statements of Cash Flows

		2021				2020				2019
Operating activities:
Net loss			(47,147	)			(36,659	)			(35,716	)
Adjustments to reconcile net loss to net cash used in operating activities:

Stock-based compensation			3,928				995				774
SARs Amortization			-				-				800
Depreciation			8				4				8
Subsidiary portion of net losses			34,400				28,820				21,745
Change in fair value of SARs liability			-				-				(82	)
Gain on debt extinguishment			(421	)			-				-
Changes in assets and liabilities:
Prepaid expenses			(38	)			38				74
Accounts payable			(1,043	)			(216	)			71
Accrued interest expense			998				525				1,184
Other liabilities			(902	)			(578	)			5,891
Other assets			109				236				(232	)
Net cash used in operating activities			(10,108	)			(6,835	)			(5,483	)

Investing activities:
Subsidiary advances, net			(95,105	)			1,332				6,781
Net cash provided by (used in) investing activities			(95,105	)			1,332				6,781

Financing activities:
Proceeds from borrowings under secured debt facilities			-				421				-
Repayments of borrowings under secured debt facilities			-				-				(1,298	)
Proceeds from the exercise of stock options			1,304				287				-
Proceeds from issuance of common stock in equity offering			103,591				5,113				-
Net cash provided by (used in) financing activities			104,895				5,821				(1,298	)

Net increase in cash and cash equivalents			(318	)			318				-
Cash and cash equivalents at beginning of period			318				-				-
Cash and cash equivalents at end of period		$	-			$	318			$	-

Supplemental disclosures of cash flow information, cash paid:
Interest payments		$	-			$	-			$	-
Income taxes paid			7				7				8

Supplemental disclosures of cash flow information, non-cash transactions:

Fair value of warrants issued to subordinated debt holders			1,546				181				162
Fair value of warrants issued for capital expenditures			1,344				-				-
Exercise of Stock Appreciation Rights added to GAFI debt			-				-				1,050
Reclassification of GAFI Non-controlling interest			-				-				8,501
Operating lease liabilities arising from obtaining right of use assets			-				2,632				640

Issuance of equity to pay off accounts payable			893				-				-

Parent Balance Sheets

Assets		2021				2020
Current assets
Cash and cash equivalents		$	-			$	318
Receivables due from subsidiaries			93,571				-
Prepaid expenses			290				252
Other current assets			116				-
Total current assets			93,977				570

Investment in AE Advanced Products Keyes , Inc.			-				12
Investment in Aemetis Property Keyes, Inc.			496				-
Investment in Aemetis International, Inc.			2,546				4,196
Investment in Aemetis Advanced Products Riverbank, Inc.			23				-
Investment in Aemetis Carbon Capture, Inc.			54				-
Total investments in Subsidiaries, net of advances			3,119				4,208

Property, plant and equipment, net			36				9
Other assets			2,475				2,700
Total Assets		$	99,607			$	7,487

Liabilities & stockholders' deficit
Current liabilities
Accounts payable		$	3,024			$	4,881
Payables due to subsidiaries			-				4,390
Mandatorily redeemable Series B convertible preferred			3,806				3,252
Other current liabilities			9,521				11,930
Total current liabilities			16,351				24,453

Long term liabilities:
Other long term debt			-				150
Operating lease liability			2,318				-
Subsidiary obligation in excess of investment
Investment in AE Advanced Fuels, Inc.			150,424				131,432
Investment in Aemetis Americas, Inc			205				205
Investment in Aemetis Biofuels, Inc.			2,738				2,738
Investment in Aemetis Technologies, Inc.			4,536				4,446
Investment in Aemetis Property Keyes, Inc.			-				247
Investment in AE Advanced Products Keyes , Inc.			383				-
Investment in Aemetis Health Products, Inc.			2,137				441
Investment in Goodland Advanced Fuels, Inc.			13,587				12,201
Investment in Aemetis Biogas LLC			27,166				15,918
Total subsidiary obligation in excess of investment			201,176				167,628

Total long term liabilities			203,494				167,778

Stockholders' deficit
Series B Preferred convertible stock			1				1
Common stock			33				23
Additional paid-in capital			205,305				93,426
Accumulated deficit			(321,227	)			(274,080	)
Accumulated other comprehensive loss			(4,350	)			(4,114	)
Total stockholders' deficit			(120,238	)			(184,744	)
Total liabilities & stockholders' deficit		$	99,607			$	7,487